Hypera (HYPE3) Q4 2025 earnings summary

Executive summary

• Net revenue reached R$7,699.2 million in 2025, up 3.4% year-over-year, driven by 6.8% retail sell-out growth, outpacing the market by 0.7 p.p., and supported by working capital optimization and improved operating efficiency.

• Record operational cash flow of R$2,574.4 million, with free cash flow at R$1,738.3 million, enabled by reduced working capital investment and improved cash conversion cycle.

• Net income from continuing operations declined 10.7% to R$1,190.8 million, mainly due to higher financial expenses and lower EBIT.

• Strengthened corporate governance with new shareholder agreements, board composition updates, and Votorantim S.A. joining the controlling group.

• Investments in marketing, innovation, and production capacity exceeded R$2.5 billion, including R$1,475.8 million in marketing and R$513.6 million in R&D.

Financial highlights

• Gross margin was 59.0% for 2025, stable year-over-year; Q4 2025 gross margin reached 61.6%, up 960bps from 4Q24.

• EBITDA from continuing operations was R$2,081.5 million for 2025 (27.0% margin), down 0.9% year-over-year; Q4 EBITDA margin at 33.5%, up 2,440bps from 4Q24.

• Net debt at year-end was R$7,665.1 million post-hedge, or 2.6x annualized EBITDA.

• Marketing expenses rose 11.3% to R$1,475.8 million; general and administrative expenses decreased 9.3% to R$331.6 million.

• Dividend/JCP distribution reached R$740.1 million (R$1.17/share).

Outlook and guidance

• Entered 2026 with improved profitability and operational efficiency, expecting strong operating cash flow conversion and sustainable sell-out growth, supported by ongoing investments in marketing, innovation, and production.

• Plans to further reduce working capital investment by lowering internal inventories and maintaining high return on invested capital.

• Anticipates higher investments in 2026, especially in the institutional market, with CapEx expected to drop significantly from 2027.

• Expects EBITDA margin to remain around recent levels, with potential for slight improvement.

• Forward-looking statements subject to market conditions, regulatory changes, and macroeconomic factors.